Evidence map›Paper›PMID 31414208›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Matthieu Colom, Nicolas Costes, Jérôme Redouté, Frédéric Dailler, Florent Gobert, Didier Le Bars, Thierry Billard, Adrian Newman-Tancredi, Luc Zimmer

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03347331 (First-in-man Study of [18F]-F13640, a PET Radiopharmaceutical for Functional 5-HT1A Receptor Imaging), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03347331 early_phase1completednot on this map

First-in-man Study of [18F]-F13640, a PET Radiopharmaceutical for Functional 5-HT1A Receptor Imaging

TypeinterventionalSponsorHospices Civils de LyonRan2018 to 2021Enrolled20ConditionsNeurological Pathology, Healthy SubjectsArms[18F]F13640
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Radiotracers for the Central Serotoninergic System.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  3. Review
  4. [Frontiers in neuroscience · 2021
    Article
  5. Article
  6. The selective 5-HTNeuropharmacology · 2020
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matthieu ColomHospices Civils de Lyon, Lyon, France.
Nicolas CostesCERMEP-imaging platform, Lyon, France.
Jérôme RedoutéCERMEP-imaging platform, Lyon, France.
Frédéric DaillerHospices Civils de Lyon, Lyon, France.
Florent GobertHospices Civils de Lyon, Lyon, France.
Didier Le BarsHospices Civils de Lyon, Lyon, France.
Thierry BillardCERMEP-imaging platform, Lyon, France.
Adrian Newman-TancrediNeurolixis Inc., Dana Point, USA.
Luc ZimmerHospices Civils de Lyon, Lyon, France. luc.zimmer@univ-lyon1.fr.ORCID 0000-0002-2805-7098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PiperidinesPyridinesHumansPositron-Emission TomographybefiradolPiperidinesPyridines

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.